You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
A Semi-Naturalistic, Open-Label Trial Examining the Effect of Prescribed Medical Cannabis on Neurocognitive Performance
|
---|---|
Published in |
CNS Drugs, November 2023
|
DOI | 10.1007/s40263-023-01046-z |
Pubmed ID | |
Authors |
Thomas R. Arkell, Brooke Manning, Luke A. Downey, Amie C. Hayley |
X Demographics
The data shown below were collected from the profiles of 192 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Germany | 34 | 18% |
Australia | 19 | 10% |
United States | 5 | 3% |
Finland | 2 | 1% |
Thailand | 2 | 1% |
Austria | 2 | 1% |
Netherlands | 2 | 1% |
United Kingdom | 1 | <1% |
New Zealand | 1 | <1% |
Other | 5 | 3% |
Unknown | 119 | 62% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 180 | 94% |
Practitioners (doctors, other healthcare professionals) | 6 | 3% |
Scientists | 5 | 3% |
Science communicators (journalists, bloggers, editors) | 1 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 14 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Professor | 2 | 14% |
Researcher | 2 | 14% |
Student > Ph. D. Student | 1 | 7% |
Student > Bachelor | 1 | 7% |
Student > Master | 1 | 7% |
Other | 1 | 7% |
Unknown | 6 | 43% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 4 | 29% |
Nursing and Health Professions | 2 | 14% |
Chemical Engineering | 1 | 7% |
Unknown | 7 | 50% |
Attention Score in Context
This research output has an Altmetric Attention Score of 188. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 February 2024.
All research outputs
#217,252
of 25,848,962 outputs
Outputs from CNS Drugs
#13
of 1,404 outputs
Outputs of similar age
#3,713
of 366,242 outputs
Outputs of similar age from CNS Drugs
#1
of 12 outputs
Altmetric has tracked 25,848,962 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,404 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.9. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 366,242 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.